These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1667342)

  • 21. Development and qualification of a size exclusion chromatography coupled with multiangle light scattering method for molecular weight determination of unfractionated heparin.
    Beirne J; Truchan H; Rao L
    Anal Bioanal Chem; 2011 Jan; 399(2):717-25. PubMed ID: 20838778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Qualitative and quantitative analysis of 2, 5-anhydro-d-mannitol in low molecular weight heparins with high performance anion exchange chromatography hyphenated quadrupole time of flight mass spectrometry.
    Yi L; Zhang Q; Meng Y; Hao J; Xie B; Gan H; Li D; Dong K; Zhang Z
    J Chromatogr A; 2018 Sep; 1569():160-167. PubMed ID: 30055911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular weight profiling of low molecular weight heparins utilizing a heparinase degraded oligosaccharide mixture as a calibrator.
    Jeske W; Ahsan A; Fareed J
    Thromb Res; 1993 Apr; 70(1):39-50. PubMed ID: 8390110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the influence of interdetector volume on local calibration in size exclusion chromatography with dual multiangle-light-scattering/concentration detection.
    Netopilík M
    J Chromatogr A; 2006 Apr; 1113(1-2):162-6. PubMed ID: 16499916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: Example of heparin.
    Monakhova YB; Diehl BWK; Do TX; Schulze M; Witzleben S
    J Pharm Biomed Anal; 2018 Feb; 149():128-132. PubMed ID: 29112901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array.
    Bertini S; Bisio A; Torri G; Bensi D; Terbojevich M
    Biomacromolecules; 2005; 6(1):168-73. PubMed ID: 15638517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the European Pharmacopeial method for molecular weight profiling of low molecular weight heparins: comparative studies utilizing an improved calibrator, ITH-3.
    Ahsan A; Jeske W; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():63-8. PubMed ID: 8395733
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.
    Sommers CD; Ye H; Kolinski RE; Nasr M; Buhse LF; Al-Hakim A; Keire DA
    Anal Bioanal Chem; 2011 Nov; 401(8):2445-54. PubMed ID: 21901459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling analysis of low molecular weight heparins by multiple heart-cutting two dimensional chromatography with quadruple time-of-flight mass spectrometry.
    Ouyang Y; Zeng Y; Rong Y; Song Y; Shi L; Chen B; Yang X; Xu N; Linhardt RJ; Zhang Z
    Anal Chem; 2015 Sep; 87(17):8957-63. PubMed ID: 26222954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Pressure Size Exclusion Chromatography (HPSEC) of humic substances: molecular sizes, analytical parameters, and column performance.
    Conte P; Piccolo A
    Chemosphere; 1999 Feb; 38(3):517-28. PubMed ID: 10901671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of heparins with different relative molecular masses (from 11,600 to 1600) by various analytical techniques.
    Volpi N
    J Chromatogr; 1993 Dec; 622(1):13-20. PubMed ID: 8120108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chain-length-dependent impact of band broadening on the molar-mass determination of synthetic polymers via size-exclusion chromatography.
    Wolpers A; Vana P
    J Chromatogr A; 2016 Aug; 1458():35-45. PubMed ID: 27393628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semisynthesis and analysis of lipophilically modified unfractionated and low molecular mass heparins.
    Malsch R; Harenberg J; Guerrini M; Torri G; Casu B; Heene DL
    Semin Thromb Hemost; 1994; 20(2):182-92. PubMed ID: 7997890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-pressure size-exclusion chromatography of anticoagulant materials.
    Muller D; Ndoume-Nze M; Jozefonvicz J
    J Chromatogr; 1984 Aug; 297():351-8. PubMed ID: 6490767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capillary Electrophoresis-Mass Spectrometry for the Analysis of Heparin Oligosaccharides and Low Molecular Weight Heparin.
    Sun X; Lin L; Liu X; Zhang F; Chi L; Xia Q; Linhardt RJ
    Anal Chem; 2016 Feb; 88(3):1937-43. PubMed ID: 26714061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monodisperse lignin fractions as standards in size-exclusion analysis: comparison with polystyrene standards.
    Botaro VR; Curvelo AA
    J Chromatogr A; 2009 May; 1216(18):3802-6. PubMed ID: 19269646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of peak-broadening and interdetector volume error on size-exclusive chromatographic analysis with dual viscometric-concentration detection using the universal calibration method.
    Netopilík M
    J Chromatogr A; 2001 Apr; 915(1-2):15-24. PubMed ID: 11358244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular weight of heparin using 13C nuclear magnetic resonance spectroscopy.
    Desai UR; Linhardt RJ
    J Pharm Sci; 1995 Feb; 84(2):212-5. PubMed ID: 7738804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of off-line size-exclusion chromatographic fractionation-matrix assisted laser desorption ionization time of flight mass spectrometry for proanthocyanidin characterization.
    Nonier MF; Absalon C; Vivas N; Vivas de Gaulejac N
    J Chromatogr A; 2004 Apr; 1033(2):291-7. PubMed ID: 15088750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of high-performance size exclusion chromatography (HPSEC) as a molecular weight screening technique for polygalacturonic acid for use in pharmaceutical applications.
    White GW; Katona T; Zodda JP
    J Pharm Biomed Anal; 1999 Sep; 20(6):905-12. PubMed ID: 10746959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.